Purchases through the above links give commission which helps fund this website
Recent literature: Vasopressin receptor 2 antagonist
Date Journal Article title
2019 Aug Alcohol Clin Exp Res Amygdala Arginine Vasopressin Modulates Chronic Ethanol Withdrawal Anxiety-Like Behavior in the Social Interaction Task.
2018 J Assoc Physicians India Efficacy and Safety of Oral Tolvaptan Therapy in Hospitalized Cirrhotic Patients with Hyponatremia.
2019 Jul J Cardiovasc Pharmacol Ther Efficacy and Safety of Tolvaptan in Patients More Than 90 Years Old With Acute Heart Failure.
2019 Medicine (Baltimore) Hypernatremia induced by low-dose Tolvaptan in a Patient with refractory heart failure: A case report.
2019 Jun Sci Rep Tolvaptan activates the Nrf2HO-1 antioxidant pathway through PERK phosphorylation.
2019 PLoS One Exercise upregulates copeptin levels which is not regulated by interleukin-1.
2019 Curr Opin Psychiatry Prospects for pharmacotherapies to treat alcohol use disorder: an update on recent human studies.
2019 Sep Brain Res Persistent cytosolic Ca2+ increase induced by angiotensin II at nanomolar concentrations in acutely dissociated fornical organ (SFO) neurons of rats.
2019 May Sci Transl Med A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder.
2019 Br J Radiol ADPKD-what the radiologist should know.
2019 May Biosci Trends A selective oral vasopressin V2-receptor antagonist for patients with end-stage liver disease awaiting liver transplantation: a preliminary study.
2019 Apr Sci Rep Drug prioritization using the semantic properties of a knowledge graph.
2019 Apr JCI Insight Site-1 protease-derived soluble (pro)renin receptor targets vasopressin receptor 2 to enhance urine concentrating capability.
2019 Jun Am J Physiol Regul Integr... Evidence for a role of arginine vasotocin receptors in the gill during salinity acclimation by a euryhaline teleost fish.
2019 Front Pharmacol Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor.
2019 Feb BMC Pediatr First experience with Tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery.
2019 Exp Hematol Oncol Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma.
2019 Drugs Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease.
2019 Biochimie Vasopressin receptors in islets enhance glucose tolerance, pancreatic beta-cell secretory function, proliferation and survival.
2019 Jan Exp Clin Endocrinol Diabetes Role of Vasopressin Receptor 2 and 3 in ACTH-Secreting Tumors and their Potential Therapeutic Implications.
2019 Dig Dis Positive Response to Tolvaptan Treatment Would Be a Good Prognostic Factor for Cirrhotic Patients with Ascites.
2019 Nephrology (Carlton) Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan.
2019 Am J Kidney Dis Determinants of Urine Volume in ADPKD Patients Using the Vasopressin V2 Receptor Antagonist Tolvaptan.
2018 Dec BMC Nephrol Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease.
2018 Dec BMC Pharmacol Toxicol Impact of continued administration of tolvaptan on cirrhotic patients with ascites.
2019 Hypertens Res Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion.
2019 Inflammation Cannabinoid CB1 Receptor Antagonist Rimonabant Decreases Levels of Markers of Organ Dysfunction and Alters Vascular Reactivity in Aortic Vessels in Late Sepsis in Rats.
2018 J Sex Med Cligosiban, A Novel Brain-Penetrant, Selective Oxytocin Receptor Antagonist, Inhibits Ejaculatory Physiology in Rodents.
2019 Drug Metab Dispos Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney Disease.
2018 Nov Int Heart J Effects of Tolvaptan on Volume Overload in Patients with Heart Failure.
2018 Int J Cardiol Heart Vasc Right ventricular enlargement predicts responsiveness to tolvaptan in congestive heart failure patients with reduced ejection fraction.
2019 Neurogastroenterol Motil Vasopressin augments TNBS-induced colitis through enteric neuronal V1a receptor-mediated COX-2-dependent prostaglandin release from mast cells in mice.
2019 Clin Drug Investig Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites.
2018 J Hum Reprod Sci A Prospective Case-control Trial to Evaluate and Compare the Efficacy and Safety of Atosiban versus Placebo in iIn vitroi Fertilization-embryo Transfer Program.
2018 Int J Nephrol Renovasc Dis Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload.
2019 Neuropsychopharmacology Oxytocin attenuates phencyclidine hyperactivity and increases social interaction and nucleus accumben dopamine release in rats.
2018 PLoS One Cardiovascular effects of H3 histamine receptor inverse agonist H4 histamine receptor agonist, clobenpropit, in hemorrhage-shocked rats.
2019 FASEB J Hydrogen sulfide upregulates renal AQP-2 protein expression and promotes urine concentration.
2018 Aug Clin J Am Soc Nephrol Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease.
2018 Sep J Neurophysiol Detection of activity-dependent vasopressin release from neuronal dendrites and axon terminals using sniffer cells.
2018 Jul BMC Nephrol Case report: a thiazide diuretic to treat polyuria induced by tolvaptan.
2018 Jun Cochrane Database Syst Rev Interventions for chronic non-hypovolaemic hypotonic hyponatraemia.
2018 Dec Mol Cell Endocrinol Oxytocin alters the morphology of hypothalamic neurons via the transcription factor myocyte enhancer factor 2A (MEF-2A).
2018 Neuropeptides Selective and non-selective OT receptor agonists induce different locomotor behaviors in male rats via central OT receptors and peripheral V1a receptors.
2018 Nov Mil Med A Non-Comparative Prospective Pilot Study of Ketamine for Sedation in Adult Septic Shock.
2018 May J Neuroendocrinol Effects of calcium and sodium on ATP-induced vasopressin release from rat isolated neurohypophysial terminals.
2018 Nat Neurosci Complex formation between the vasopressin 1b receptor, β-arrestin-2, and the μ-opioid receptor underlies morphine tolerance.
2018 Heart Vessels The effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge.
2018 Nephrology (Carlton) Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide.
2018 May Anal Biochem Quantification of receptor activation by oxytocin and vasopressin in endocytosis-coupled bioluminescence reduction assay using nanoKAZ.
2018 Apr Arch Argent Pediatr [Tolvaptan in a pediatric cardiorenal syndrome: What is its role?]
2018 Biomed Pharmacother Steviol slows renal cyst growth by reducing AQP2 expression and promoting AQP2 degradation.
2018 Korean J Physiol Pharmacol Oxytocin produces thermal analgesia via vasopressin-1a receptor by modulating TRPV1 and potassium conductance in the dorsal root ganglion neurons.
2018 Medicine (Baltimore) A case report with shock induced by tolvaptan in an elderly patient with congestive heart failure.
2018 J Int Med Res Hormone treatments in congestive heart failure.
2018 Mar Circ J Can Tolvaptan Protect Renal Function in the Early Postoperative Period of Cardiac Surgery? - Results of a Single-Center Randomized Controlled Study.
2017 Electrolyte Blood Press Edematous Hyponatremia Treated with Tolvaptan in a Patient with Amyotrophic Lateral Sclerosis.
2018 Int Heart J Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics.
2018 May Neuropharmacology The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement.
2018 Jan Ann Transplant Tolvaptan for Fluid Management in Living Donor Liver Transplant Recipients.
2017 Dec Int J Mol Sci Hyaluronan Production by Renomedullary Interstitial Cells: Influence of Endothelin, Angiotensin II and Vasopressin.
2018 Biochem Biophys Rep Proteomic analysis of AQP11-null kidney: Proximal tubular type polycystic kidney disease.
2018 Neuropharmacology Oxytocin inhibits the rat medullary dorsal horn Sp5cC1 nociceptive transmission through OT but not V1A receptors.
2017 ESC Heart Fail Influence of renal impairment on aldosterone status, calcium metabolism, and vasopressin activity in outpatients with systolic heart failure.
2017 Nov N Engl J Med Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
2018 Alcohol Clin Exp Res V1b Receptor Antagonist SSR149415 and Naltrexone Synergistically Decrease Excessive Alcohol Drinking in Male and Female Mice.
2017 Oct J Clin Med Is Exaggerated Release of Arginine Vasopressin an Endocrine Disorder? Pathophysiology and Treatment.
2018 Heart Vessels Effects of tolvaptan on urine output in hospitalized heart failure patients with hypoalbuminemia or proteinuria.
2018 Jan Neurosci Lett Arginine vasopressin antagonizes the effects of prostaglandin E2 on the spontaneous activity of warm-sensitive and temperature-insensitive neurons in the medial preoptic area in rats.
2017 Horm Behav Oxytocin induces penile erection and yawning when injected into the bed nucleus of the stria terminalis: Involvement of glutamic acid, dopamine, and nitric oxide.
2017 Psychopharmacology (Berl) Role of vasopressin V1a receptor in ∆9-tetrahydrocannabinol-induced cataleptic immobilization in mice.
2018 Heart Vessels Favorable effects of early tolvaptan administration in very elderly patients after repeat hospitalizations for acute decompensated heart failure.
2017 Front Psychiatry The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish.
2017 Aug BMC Vet Res Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
2017 PLoS One Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias.